AerSale Corporation
NASDAQ:ASLEAirlines, Airports & Air Services
-$0.11 today
- Market cap
- $242.47M
- Beta
- 0.27
- P/E (TTM)
- 25.5
- EPS (TTM)
- $0.25
Volume 0.30M
Average 0.37M
ASLE Total Liabilities
Everything the company owes to creditors and other parties.
AerSale CorporationNASDAQ: ASLE
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities rises 2.4% from a year ago
Total liabilities stood at $245.28M at the end of Q1 FY2026, up 2.4% from a year earlier and up 13.5% from the prior quarter. Over 3 fiscal years it compounded at +35.6% a year.
Context
- Total liabilities amounted to 36.7% of total assets at the end of Q1 FY2026, down 0.4 pp from a year earlier.
- Total liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +2.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 216.04M USD
- Year-over-year change
- +44.9%
- 4-year CAGR
- +28.8%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 216.04M | +44.9% |
| FY2024 | 2024-12-31 | 149.1M | +36.9% |
| FY2023 | 2023-12-31 | 108.92M | +25.8% |
| FY2022 | 2022-12-31 | 86.6M | +10.2% |
| FY2021 | 2021-12-31 | 78.61M | — |
Total Liabilities vs competitors
How ASLE compares with its peers on the latest reported figures
- ASLE's Mar 2026 total liabilities of $245.28M is the 6th highest of the 11 companies compared; the peer median is $259.06M.
- Its year-over-year change of +2.4% is the 6th highest of 11, against a peer median of +1.5%.
- Total liabilities amounts to 36.7% of total assets for ASLE, versus a peer median of 57.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.16B | +4.0% | +1.4% | 62.8% | |
| Mar 2026 | $693.8M | -3.4% | +100.2% | 81.7% | |
| Apr 2026 | $610.4M | -1.1% | -1.0% | 68.0% | |
| Mar 2026 | $521.83M | +5.3% | +5.5% | 116.1% | |
| Mar 2026 | $345.89M | +74.9% | +13.2% | 59.8% | |
| Mar 2026 | $245.28M | +2.4% | +35.6% | 36.7% | |
| Mar 2026 | $172.23M | +54.4% | +12.2% | 54.1% | |
SBCSBC Medical Group Holdings Incorporated | Mar 2026 | $117.64M | +101.8% | -0.1% | 30.3% |
| Mar 2026 | $91.65M | -54.9% | -15.9% | 50.1% | |
| Mar 2026 | $55.23M | -42.1% | +83.0% | 18.6% | |
| Mar 2026 | $12.28M | -17.9% | -34.4% | 8.6% | |
| Peer median (excluding ASLE) | $259.06M | +1.5% | +3.4% | 57.0% | |
Competitors are the stored peer set for ASLE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 130.19M | 147.19M | 5.87M | 4.7M | 4.38M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 29.35M | 28.27M | 32.87M | 42.81M | 48.46M |
| Inventory | 81.76M | 117.49M | 177.77M | 224.83M | 211.06M |
| Other Current Assets | 15.95M | 13.02M | 12.51M | 11.69M | (585K) |
| Total Current Assets | 271.53M | 333.56M | 264.77M | 284.03M | 268.99M |
| Property, Plant & Equipment (Net) | 80.71M | 75.55M | 81.69M | 69.44M | 62.14M |
| Goodwill | 19.86M | 19.86M | 19.86M | 19.86M | 19.86M |
| Intangible Assets | 26.24M | 24.11M | 21.99M | 20.53M | 18.35M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 10.01M | 11.29M | 12.2M | 10.17M | 8.78M |
| Other Non-current Assets | 79.13M | 67.21M | 153.43M | 200.7M | 262.36M |
| Total Non-current Assets | 215.96M | 198.02M | 289.16M | 320.69M | 371.48M |
| Total Assets | 487.49M | 531.58M | 553.94M | 604.72M | 640.47M |
| Account Payables | 19.97M | 21.13M | 29.9M | 34.18M | 29.65M |
| Short-term Debt | 0 | 0 | 1.28M | 605K | 5.31M |
| Tax Payables | 3.69M | 142K | 105K | 120K | 329K |
| Deferred Revenue | 36.07M | 18.44M | 4.47M | 26.69M | 29.14M |
| Other Current Liabilities | 6.29M | 6.04M | 2.24M | 1.61M | 4.18M |
| Total Current Liabilities | 67.91M | 52.84M | 45.71M | 74.97M | 72.43M |
| Long-term Debt | 0 | 0 | 36.28M | 40.44M | 111.34M |
| Deferred Tax Liabilities | 1.11M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 9.59M | 5.48M | 2.55M | 3.12M | 4.08M |
| Total Non-current Liabilities | 10.7M | 33.76M | 63.21M | 74.13M | 143.61M |
| Total Liabilities | 78.61M | 86.6M | 108.92M | 149.1M | 216.04M |
| Common Stock | 5K | 5K | 5K | 5K | 5K |
| Retained Earnings | 94.97M | 138.83M | 133.27M | 139.12M | 147.7M |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 408.88M | 444.98M | 445.02M | 455.62M | 424.43M |
| Total Debt | 0 | 32.71M | 66.53M | 75.97M | 144.83M |
| Net Debt | (130.19M) | (114.48M) | 60.66M | 71.27M | 140.45M |
AerSale Corporation
NASDAQ:ASLE
Intrinsic Alpha fair value
Locked
Current Price
$5.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.